Chiasma, Inc. (CHMA): Price and Financial Metrics


Chiasma, Inc. (CHMA): $3.76

-0.24 (-6.00%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

CHMA POWR Grades


  • Growth is the dimension where CHMA ranks best; there it ranks ahead of 63.2% of US stocks.
  • CHMA's strongest trending metric is Momentum; it's been moving down over the last 31 weeks.
  • CHMA's current lowest rank is in the Stability metric (where it is better than 2.59% of US stocks).

CHMA Stock Summary

  • For CHMA, its debt to operating expenses ratio is greater than that reported by just 0.53% of US equities we're observing.
  • With a price/sales ratio of 78.91, Chiasma Inc has a higher such ratio than 96.09% of stocks in our set.
  • Revenue growth over the past 12 months for Chiasma Inc comes in at 2,033.8%, a number that bests 99.37% of the US stocks we're tracking.
  • Stocks that are quantitatively similar to CHMA, based on their financial statements, market capitalization, and price volatility, are FULC, VYNE, FIXX, PTGX, and RDHL.
  • CHMA's SEC filings can be seen here. And to visit Chiasma Inc's official web site, go to www.chiasmapharma.com.

CHMA Valuation Summary

  • In comparison to the median Healthcare stock, CHMA's price/sales ratio is 2150% higher, now standing at 81.
  • CHMA's price/sales ratio has moved NA NA over the prior 73 months.
  • Over the past 73 months, CHMA's price/earnings ratio has gone up 148.

Below are key valuation metrics over time for CHMA.

Stock Date P/S P/B P/E EV/EBIT
CHMA 2019-11-13 NA 2.3 -6.8 -6.2
CHMA 2019-01-07 NA 1.9 -2.7 -2.3
CHMA 2018-06-21 NA 0.7 -1.4 -0.8
CHMA 2017-04-26 NA 0.5 -0.7 -0.1
CHMA 2016-09-29 NA 0.7 -1.0 -0.6
CHMA 2015-12-01 NA 3.4 -181.3 -211.2

CHMA Price Target

For more insight on analysts targets of CHMA, see our CHMA price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $9.10 Average Broker Recommendation 1.7 (Moderate Buy)

CHMA Stock Price Chart Interactive Chart >

Price chart for CHMA

CHMA Price/Volume Stats

Current price $3.76 52-week high $5.74
Prev. close $4.00 52-week low $2.77
Day low $3.76 Volume 8,196,700
Day high $4.10 Avg. volume 2,123,740
50-day MA $4.29 Dividend yield N/A
200-day MA $3.96 Market Cap 217.68M

Chiasma, Inc. (CHMA) Company Bio


Chiasma Inc. focuses on developing and commercializing oral forms of therapies for patients suffering from orphan diseases. The company was founded in 2001 and is based in Newton, Massachusetts.


CHMA Latest News Stream


Event/Time News Detail
Loading, please wait...

CHMA Latest Social Stream


Loading social stream, please wait...

View Full CHMA Social Stream

Latest CHMA News From Around the Web

Below are the latest news stories about Chiasma Inc that investors may wish to consider to help them evaluate CHMA as an investment opportunity.

When Will Chiasma, Inc. (NASDAQ:CHMA) Breakeven?

Chiasma, Inc. ( NASDAQ:CHMA ) is possibly approaching a major achievement in its business, so we would like to shine...

Yahoo | July 30, 2021

Pulmatrix appoints Director Anand Varadan

Pulmatrix, Inc. (NASDAQ: PULM), a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented iSPERSE™ technology, today announced the appointment of Anand Varadan to its Board of Directors, effective July 26, 2021. Mr. Varadan brings expertise in commercialization and successful product launches. In addition, Mark Iwicki stepped down from his role on the Board of Directors effective July 23, 2021.

Yahoo | July 27, 2021

SHAREHOLDER ALERT: Halper Sadeh LLP Investigates RAVN, BOCH, ONEM, CHMA; Shareholders are Encouraged to Contact the Firm

NEW YORK, July 24, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Raven Industries, Inc. (NASDAQ: RAVN) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to CNH Industrial N.V. for $58.00 per share. If you are a Raven shareholder, click here to learn more about your rights and options. Bank of Commerce Holdings (NASDAQ: BOCH) concerning poten

Yahoo | July 24, 2021

SHAREHOLDER ALERT: WeissLaw LLP Reminds ONEM, BOCH, CHMA, and QTS Shareholders About Its Ongoing Investigations

If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact:

Yahoo | July 22, 2021

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates WRI, WBT, CHMA, XOG, USCR, ONEM; Shareholders are Encouraged to Contact the Firm

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

Yahoo | July 18, 2021

Read More 'CHMA' Stories Here

CHMA Price Returns

1-mo N/A
3-mo -21.01%
6-mo 27.03%
1-year -15.70%
3-year 4.44%
5-year 23.28%
YTD -13.56%
2020 -12.30%
2019 59.49%
2018 82.94%
2017 -12.82%
2016 -90.04%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8595 seconds.